Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-17-004098

Options or other derivatives

  • Director acquired 13,718 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McDonough Cameron Geoffrey Director 2017-02-13 Grant or award · Stock Option (Right to Buy) +13,718 13,718 D: show line 1 in the form
Loading xslF345X03/doc4.xml…